...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    cncr-img

    Loncar Cancer Immunotherapy ETF, ETF

    CNCR

    NMQ

    $8.87

    -$0.23

    (-2.53%)

    Provider: Range Cancer Category: Health
    Overview Returns Holdings Sector Breakdown FAQs

    Price Chart

    Key Metrics

    Expense Ratio info-icon
    The expense ratio is how much you pay a mutual fund or ETF per year, expressed as a percent of your investments. It is a measure of the fund's operating costs relative to assets.
     0.79%
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     2.23K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     1.00
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $7.88 L
    $16.27 H
    $8.87

    About Loncar Cancer Immunotherapy ETF, ETF

    The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index. more

    Provider: Range CancerCategory: Health

    Returns

    Time FrameCNCRS&P500
    1-Week Return2.07%-1%
    1-Month Return-18.1%-5.24%
    3-Month Return-24.19%-9.21%
    6-Month Return-42.03%-7.68%
    1-Year Return-39.54%6.77%
    3-Year Return-47.33%22.73%
    5-Year Return-59.16%92.61%
    10-Year Return-64.65%156.23%

    Largest Holdings

    Stock name Ticker Weight
    SMMT-img Summit Therapeutics PLC
    		SMMT
    2.19%
    FATE-img Fate Therapeutics Inc
    		FATE
    2.07%
    YMAB-img Y mAbs Therapeutics
    		YMAB
    2.01%
    SDGR-img Schrodinger Inc
    		SDGR
    1.93%
    DNA-img Ginkgo Bioworks Holdings
    		DNA
    1.9%
    TSVT-img 2Seventy Bio Inc
    		TSVT
    1.8%
    BNTX-img BioNTech SE
    		BNTX
    1.76%
    EXEL-img Exelixis Inc
    		EXEL
    1.76%
    NUVB-img Nuvation Bio Inc
    		NUVB
    1.73%
    NK-img NantKwest Inc
    		NK
    1.71%

    Sector Breakdown

    Sector Weight
    Health care
    		100.00%

    Discover more

    spy-img

    SPDR S&P 500 ETF Trust
    qqq-img

    Invesco QQQ Trust
    vti-img

    Vanguard Total Stock Market Index Fund ETF Shares
    iefa-img

    iShares Core MSCI EAFE ETF
    bnd-img

    Vanguard Total Bond Market Index Fund ETF Shares
    ibit-img

    iShares Bitcoin Trust
    vug-img

    Vanguard Growth Index Fund ETF Shares
    gld-img

    SPDR® Gold Shares
    tlt-img

    iShares 20+ Year Treasury Bond ETF

    FAQs

    What is Loncar Cancer Immunotherapy ETF (CNCR) ETF share price today?

    Loncar Cancer Immunotherapy ETF (CNCR) share price today is $8.87.

    Can Indians buy Loncar Cancer Immunotherapy ETF shares?

    Yes, Indians can buy shares of Loncar Cancer Immunotherapy ETF (CNCR) on Vested. To buy CNCR from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.

    Can Fractional shares of Loncar Cancer Immunotherapy ETF be purchased?

    Yes, you can purchase fractional shares of Loncar Cancer Immunotherapy ETF (CNCR) on Vested. You can start investing in Loncar Cancer Immunotherapy ETF (CNCR) with a minimum investment of $1.

    How to invest in Loncar Cancer Immunotherapy ETF shares from India?
    • Click on Sign Up or Invest in CNCR ETF at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Loncar Cancer Immunotherapy ETF shares
    What is Loncar Cancer Immunotherapy ETF's 52-week high and low ETF share price?

    The 52-week high price of Loncar Cancer Immunotherapy ETF (CNCR) is $16.27. The 52-week low price of Loncar Cancer Immunotherapy ETF (CNCR) is $7.88.

    What is Loncar Cancer Immunotherapy ETF's ticker or symbol?

    The stock symbol (or ticker) of Loncar Cancer Immunotherapy ETF is CNCR.

    Can I set up automatic investments (SIP) in Loncar Cancer Immunotherapy ETF shares?

    Yes, you can setup SIP in Loncar Cancer Immunotherapy ETF shares. Follow the below steps to create the SIP:

    • Sign up on Vested and complete your KYC for US Stocks
    • Transfer funds to your US Stocks account
    • Navigate to CNCR ticker page and set up your recurring investment
    What is the historical performance of Loncar Cancer Immunotherapy ETF ETF?

    Here is the historical performance of CNCR on the Vested app.

    • 1-Year Return: -39.54%
    • 3-Year Return: -47.33%
    • 5-Year Return: -59.16%
    • 1-Week Return: 2.07%
    • 1-Month Return: -18.1%
    • 3-Month Return: -24.19%

    You can also access the top holdings, the expense ratio, and the sector breakdown for Loncar Cancer Immunotherapy ETF on Vested.

    What is the expense ratio of Loncar Cancer Immunotherapy ETF?

    The expense ratio of Loncar Cancer Immunotherapy ETF (CNCR) is 0.79%.

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top